Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Tirzepatide 30mg research vial — reference-grade research material UAEVialTap to zoom
Research PeptidesIn stock

Tirzepatide 30mg

30 mg · Lyophilized

4.8· 12 VaultLabs customer reviews
Third-party testedVaultLabs tested · 99.91%

Price (AED)

AED 599

per vial · AED 19.97 / mg

Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

Minimum order AED 150 merchandise, before discount, delivery, and VAT.

Or split into 4 interest-free payments withtamara

24h dispatch

Buy more, save moreUp to 20% off this product

Add 1 more to save 5%

WhatsAppTelegram
Secure checkout
  • tamaraTamara
  • VISAVisa
  • Mastercard
  • PayApple Pay
  • PayGoogle Pay
  • CODCash on delivery

Free UAE delivery unlockedAED 500

  1. Order today

    Pay in AED

  2. Dispatched in 24h

    7 days a week

  3. Delivered

    Next-day option

Third-party testedVaultLabs tested · 99.91%

Every batch is tested by an independent lab before release, then checked on the VaultLabs certificate. The lab report is available on request.

Certificate for this lotVerify lot
  • COA-backed batch
  • Lot-tracked vial
  • Secure checkout
  • Returns policy

Delivery to your emirate

Dispatch: Dispatched within 24 hours, 7 days a week

Arrival: After dispatch: next-day options arrive in 1 UAE business day after dispatch; standard arrives in 4 UAE business days after dispatch.

This amount meets the free-delivery threshold — confirmed after discounts at checkout.

Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

View comparison

Volume orders: wholesale access

For in vitro research use only. Not for human or animal consumption. Documentation published when available per batch.

Molecular identity

Molecular weight
4,813.53 Da
Chain length
39 amino acids
Structure
Dual GIP / GLP-1 receptor agonist

Amino-acid sequence

C20 fatty-diacid-conjugated 39-residue dual-agonist backbone (LY3298176).

Weekly albumin-bound kinetics, as characterised on the US prescribing information.

Identity fields above are registry and catalogue descriptions. They are not pharmacokinetic measurements of this lot and are not a substitute for the published certificate.

Certificate of Analysis

Verified COA for this product

Your current batch LOT is loaded automatically. View the published certificate, download a PDF, or verify a different vial below.

View COAScan QR to verify

Verify LOT

Current batch pre-filled — edit to check a different vial.

Full COA page

Technical specifications

Product overview

Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide referenced extensively in metabolic pathway research literature. VaultLabs supplies Tirzepatide 30mg lyophilized research material for controlled in vitro laboratory workflows in the UAE. Catalog documentation describes material identity and lot data only — not clinical or personal use. Research use only.

Lyophilized incretin dual-agonist peptide · HPLC verification on published COA · VaultLabs code VL-TIRZ-30 · Appearance: White to off-white lyophilized powder

Research context

  • 30 mg lyophilized tirzepatide · HPLC on published COA
  • Research hub: /research/tirzepatide
  • Verify lot via /batch-verify

Technical specifications

Full product name
Tirzepatide 30mg
Product category
Research Peptides
Product code
VL-TIRZ-30
Strength / amount
30 mg
Physical form
Lyophilized
Purity
99.91%
Testing method
HPLC
Laboratory
VaultLabs Laboratory
Test date
2026-07-15
Current lot number
VL-TIRZ-20260801
Manufacturing / packaging date
2026-07-01

Chemical identifiers

Chemical name
Tirzepatide
CAS number
2023788-19-2
Molecular formula
C225H348N48O68
Molecular weight
4813.53 g/mol
Synonyms
LY3298176, dual GIP/GLP-1 receptor agonist peptide
Product code
VL-TIRZ-30
Grade
Research grade — for in vitro laboratory research use only
Material class
Lyophilized incretin dual-agonist peptide

Current batch documentation

COA available for current shipping lotLOT: VL-TIRZ-20260801
View certificateVerify batch

Storage and handling

2–8 °C · protect from light

Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Shipping information

Supply role
UAE distributor — dispatched from Dubai
Dispatch location
Dubai, United Arab Emirates
Shipping / packaging
Cold-chain aware insulated packaging on UAE dispatch with lot traceability.
Availability
In stock
Dispatch estimate
Dispatched within 24 hours, 7 days a week
VAT
Listed prices are exclusive of VAT. UAE VAT (5%) is added once at checkout on the post-discount merchandise subtotal, the delivery fee, and any payment fee.

Packaging and dispatch

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

Research-use policy

Products are intended exclusively for in vitro laboratory research, analytical testing, and scientific study. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Full research-use policy

Frequently asked questions

No. Tirzepatide 30mg is supplied strictly as a laboratory reference material for in vitro research. It is not for human or animal consumption, and not for medical, personal or diagnostic use. The declaration made at checkout is retained with the order record.

CAS registry number 2023788-19-2, molecular formula C225H348N48O68, molecular weight 4813.53 g/mol. Full identity data and the supporting literature are published on the Tirzepatide 30mg compound monograph.

30 mg of lyophilized, sealed and lot-numbered. Lyophilized incretin dual-agonist peptide · HPLC verification on published COA · VaultLabs code VL-TIRZ-30 · Appearance: White to off-white lyophilized powder

2–8 °C · protect from light. Store sealed lyophilized material at 2–8 °C, protected from light and moisture until opened under laboratory conditions.

Yes. Every vial carries a lot number that resolves through batch verification to the certificate published for that batch. A purity figure belongs to the lot it was measured on and should not be generalised across the product line.

The current published lot is VL-TIRZ-20260801, batch B-TIRZ-2026-08. The laboratory named on that certificate is VaultLabs Laboratory. Published purity is 99.91% by HPLC. Janoshik Analytical and METS Lab appear on a batch only when that lot has their report.

Cold-chain aware insulated packaging on UAE dispatch with lot traceability.

No. VaultLabs supplies reference-grade materials and published analytical documentation only. We cannot advise on dosage, administration, or use in humans or animals. Handling and reconstitution references are available in the research library.

Related research materials

VaultLabs customer reviews

Reviews for Tirzepatide 30mg

All site reviews

Customer feedback comments on packaging, delivery, support, and documentation — not medical outcomes. Reviews are moderated for authenticity and research-use compliance. Tap a review to see who wrote it.

Questions & answers

Questions about Tirzepatide 30mg

No published questions for this product yet. Ask about documentation, storage, specifications, delivery or wholesale terms and our team will answer here.

Submit feedback

Review Tirzepatide 30mg

Your review will appear on this product page after moderation. Focus on packaging, delivery, support, or documentation — optional photo of packaging (no product effects).

Third-party testedVaultLabs tested · 99.91%

Tested before release

Each catalogue batch is tested by an independent laboratory before release, then checked again on the VaultLabs certificate. The laboratory report for this lot is available on request, and the laboratory is named on that report.

Lot VL-TIRZ-20260801 · 99.91%

Related research & guides

Reference material and background reading related to Tirzepatide 30mg.

Traceable lot numbersCOA verificationBatch verificationDocumentation availableLab testing standards